Healthcare
Live Price
Offline$4.82
+0.00% today
1Y Change
—
Window
No data
Historical coverage is still loading
We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
CSAM Health Group AS (CSAMF) is a Healthcare stock with a market cap of $98.80M. The stock last traded around $4.82. Baseline metrics include revenue growth of +3.5%, EPS growth of -157.5%, a dividend yield of 1.2%. What stands out right now is revenue +3.5%, EPS -157.5%, free cash flow +1285.7% with operating margin 10.1% and ROIC 3.2%. The dividend is present but secondary, with a yield around 1.2%. Valuation already assumes a fairly strong business story at P/E 125.4 and price/sales 1.7. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CSAMF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
CSAMF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
CSAMF Max Drawdown
—
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for CSAMF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$228.5M
-30.6% YoY
FY Net Income
-$9.2M
+89.3% YoY
Free Cash Flow
$767.0K
+111.5% YoY
Revenue Growth
+3.5%
EPS Growth
-157.5%
Gross Margin
74.5%
Net Margin
1.3%
Income statement
NOK
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 425M | 410M | 367M | 329M | 229M |
| Gross Profit | 394M | 378M | 333M | 294M | 203M |
| Operating Income | -3M | 129M | -90M | -42M | 17M |
| EBITDA | 56M | 228M | -10M | 21M | 58M |
| Net Income | -59M | 104M | -132M | -87M | -9M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
NOK
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | 122M | 117M | 192M | 275M | 302M |
| Total Assets | 788M | 769M | 694M | 856M | 661M |
| Total Liabilities | 763M | 674M | 665M | 684M | 413M |
| Shareholder Equity | 25M | 95M | 29M | 172M | 248M |
| Total Debt | 483M | 477M | 494M | 491M | 284M |
| Net Debt | 361M | 360M | 303M | 217M | -18M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
28M
+28.8% YoY
Capital Expenditures
28M
+3.8% YoY
Free Cash Flow
767K
+111.5% YoY
Key ratios
Gross Margin
74.5%
Operating Margin
10.1%
Net Margin
1.3%
ROE
21.7%
Debt / Equity
18.33x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.